We are live on ! Find out more
Two Sigma Advisers

Two Sigma Advisers Portfolio holdings

AUM $51.4B
1-Year Est. Return 31.07%
This Fund
S&P 500
This Quarter Est. Return
+1.2%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$38.6B
AUM Growth
+$669M
Cap. Flow
+$1.61B
Cap. Flow %
4.18%
Top 10 Hldgs %
13.49%
Holding
2,814
New
394
Increased
941
Reduced
1,071
Closed
396

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$486M
2
PFE icon
Pfizer
PFE
+$433M
3
AAPL icon
Apple
AAPL
+$430M
4
TSLA icon
Tesla
TSLA
+$401M
5
ROKU icon
Roku
ROKU
+$374M

Sector Composition

Rank Sector Weight
1 Technology 24.02%
2 Healthcare 23.8%
3 Communication Services 9.19%
4 Financials 8.73%
5 Consumer Discretionary 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUC
2376
ATIF Holdings
AUC
$74.2M
$46K ﹤0.01%
567
-269
-32% -$18.6K
DBGI
2377
Digital Brands Group
DBGI
$8.88M
0
KRMD icon
2378
KORU Medical Systems
KRMD
$189M
$44K ﹤0.01%
15,300
-28,600
-65% -$94.6K
VANI icon
2379
Vivani Medical
VANI
$110M
$44K ﹤0.01%
+4,600
New +$51.8K
DYNT
2380
DELISTED
Dynatronics Corp
DYNT
$43K ﹤0.01%
5,879
+59
+1% +$382
ASRV icon
2381
AmeriServ Financial
ASRV
$77.5M
$42K ﹤0.01%
10,800
XIN
2382
DELISTED
Xinyuan Real Estate
XIN
$42K ﹤0.01%
2,380
-640
-21% -$13.4K
AIHS icon
2383
Senmiao Technology Ltd
AIHS
$19.8M
$41K ﹤0.01%
693
-175
-20% -$12.2K
PTN
2384
Palatin Technologies
PTN
$13.7M
$41K ﹤0.01%
75
+35
+88% +$21.9K
BKYI
2385
BIO-key International
BKYI
$4.76M
$39K ﹤0.01%
+62
New +$36.6K
DSS icon
2386
DSS Inc
DSS
$5.39M
$38K ﹤0.01%
+1,567
New +$40K
AMPG icon
2387
AmpliTech
AMPG
$118M
$37K ﹤0.01%
10,300
-7,400
-42% -$28.5K
TNXP icon
2388
Tonix Pharmaceuticals
TNXP
$160M
0
NMTR
2389
DELISTED
9 Meters Biopharma
NMTR
$36K ﹤0.01%
1,400
-75,725
-98% -$1.78M
BCLI
2390
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$35K ﹤0.01%
713
-600
-46% -$31.6K
MITO
2391
DELISTED
Stealth BioTherapeutics Corp. ADS
MITO
$35K ﹤0.01%
25,400
+2,700
+12% +$3.66K
ASLN
2392
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$34K ﹤0.01%
475
-363
-43% -$41.3K
GHSI
2393
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
$31K ﹤0.01%
+490
New +$32.6K
BLNE
2394
Beeline Holdings
BLNE
$28.8M
$30K ﹤0.01%
58
-5
-8% -$3.31K
NTBL
2395
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$30K ﹤0.01%
+411
New +$32.1K
ARTL icon
2396
Artelo Biosciences
ARTL
$2.68M
$28K ﹤0.01%
132
-831
-86% -$211K
JG
2397
Aurora Mobile
JG
$33.4M
$28K ﹤0.01%
850
-495
-37% -$22.1K
DTEA
2398
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
$28K ﹤0.01%
11,200
-10,300
-48% -$36.2K
CTEK
2399
DELISTED
CynergisTek, Inc.
CTEK
$26K ﹤0.01%
14,300
-1,400
-9% -$2.84K
SNES icon
2400
SenesTech
SNES
$7.16M
$21K ﹤0.01%
6
-3
-33% -$11.6K

Similar funds

Two Sigma Advisers's Q3 2021 Portfolio in Review

As of Q3 2021, Two Sigma Advisers held 2,814 positions worth $38.6B, up 1.8% from $37.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Two Sigma Advisers deployed $1.61B of net new capital in Q3 2021, opening 394 new positions and adding to 941 existing holdings. Its largest new stake was Danaher: 1,248,470 shares worth $337M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 20% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $486M trimmed.

  • Two Sigma Advisers's largest Q3 2021 buy was Danaher: 1,248,470 shares worth $337M.
  • Two Sigma Advisers added most to Microsoft in Q3 2021, an estimated $550M increase.
  • Two Sigma Advisers's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $486M.
  • Two Sigma Advisers fully exited Roku in Q3 2021, selling an estimated $374M.
  • Two Sigma Advisers's ten largest holdings make up 13% of its $38.6B portfolio in Q3 2021.
  • Two Sigma Advisers opened 394 new positions and closed 396 in Q3 2021.
  • Two Sigma Advisers's portfolio value rose 1.8% quarter-over-quarter to $38.6B.

Based on Two Sigma Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.